Spiroheptanyl hydantoins as rock inhibitors

A compound of Formula (I):

• or a pharmaceutically acceptable salt thereof, wherein:
• Ring A is 6-membered heteroaryl comprising carbon and 1-2 nitrogen atoms;
• R1 is selected from H, C1-7 alkyl, C2-7 alkenyl, and C2-7 alkynyl, wherein said alkyl, alkenyl, and alkynyl are substituted with 1-4 R7;
• R2 is H;
• R3 is H;
• R6, at each occurrence, is independently selected from H, halogen, C1-6 alkyl, and C1-4 alkoxy;
• R7, at each occurrence, is independently selected from H, ═O, NO2, halogen, C1-7 alkyl, C2-4 alkenyl, C2-4 alkynyl, C1-4 alkoxy, CN, OH, CHF2, CF3, —(CH2)n—CO2H, —(CH2)n—CO2(C1-4 alkyl), —NHCOH, —NHCO(C1-4 alkyl), —NHCOCF3, —NHCO2(C1-4 alkyl), —NHCO2(CH2)2O(C1-4 alkyl), —NHCO2(CH2)3O(C1-4 alkyl), —NHCO2(CH2)2OH, —NHCO2(CH2)2NH2, —NHCO2(CH2)2N(C1-4 alkyl)2, —NHCO2CH2CO2H, —CH2NHCO2(C1-4 alkyl), —NHSO2(C1-4 alkyl), —S(O)p(C1-4 alkyl), —SO2NH2, —SO2NH(C1-4 alkyl), —SO2N(C1-4 alkyl)2, —SO2NH(CH2)2OH, and —SO2NH(CH2)2O(C1-4 alkyl), wherein said alkyl, alkenyl, alkynyl, and alkoxy are substituted with 0-4 R9;
• R9, at each occurrence, is independently selected from halogen, OH, ═O, CN, NO2, C1-4 alkyl, C1-4 alkoxy, CO(C1-4 alkyl), CO2H, CO2(C1-4 alkyl), —(CHR10)nNRaRa, S(O)p(C1-4 alkyl), —(CHR10)nCONRaRa, —(CHR10)nNRaCO(C1-4 alkyl), —(CHR10)nOCONRa(CH2)nCO2Ra, S(O)pC1-4 alkyl, and S(O)pNRaRa;
• R10, at each occurrence, is independently selected from H and C1-4 alkyl;
• R11 is H;
• R12 and R13 are independently H;
• Ra, at each occurrence, is independently selected from H, C1-4 alkyl, —(CH2)nOH, CO(C1-4 alkyl), COCF3, CO2(C1-4 alkyl), —CONH2, —CONH—C1-4 alkylene—CO2(C1-4 alkyl), C1-4 alkylene—CO2(C1-4 alkyl), Rc, CO2Rc, and CONHRc;
• alternatively, Ra and Ra are taken together with the nitrogen atom to which they are attached to form a 4- to 10-membered heterocycle, wherein said alkyl, alkylene, and heterocycle are substituted with 0-4 Rb;
• Rb, at each occurrence, is independently selected from ═O, OH, halogen, C1-4 alkyl, C1-4 alkoxy, OCF3, OC(O)C1-4 alkyl, NH2, NO2, N(C1-4 alkyl)2, CO(C1-4 alkyl), CO(C1-4 haloalkyl), CO2H, CO2(C1-4 alkyl), CONH2, —CONH(C1-4 alkyl), —CON(C1-4 alkyl)2, —CONH—C1-4 alkylene—O(C1-4 alkyl), —CONH—C1-4 alkylene—NH(C1-4 alkyl), —CONH—C1-4 alkylene—N(C1-4 alkyl)2, —C1-4 alkylene—O—P(O)(OH)2, —NHCO2(C1-4 alkyl), —Rc, CORc, CO2Rc, and CONHRc, wherein said alkyl and alkoxy are substituted with Rd;
• Rc, at each occurrence, is independently selected from —(CH2)n—C3-6 cycloalkyl, —(CH2)n-phenyl, and —(CH2)n-5- to 6-membered heterocycle containing carbon atoms and 1-4 heteroatoms selected from the group consisting of:
• N, NH, N(C1-4 alkyl), O, and S(O)p, wherein each ring moiety is substituted with 0-2 Rd;
• Rd, at each occurrence, is independently selected from ═O, halogen, —OH, C1-4 alkyl, NH2, NH(C1-4 alkyl), N(C1-4 alkyl)2, C1-4 alkoxy, and —NHCO(C1-4 alkyl);
• n, at each occurrence, is independently selected from 0, 1, 2, 3, and 4;
• and
• p, at each occurrence, is independently selected from 0, 1, and 2.